Gazyva (obinutuzumab) is a monoclonal antibody that affects the actions of the body's immune system. Obinutuzumab strengthens your immune system to help your body fight against tumor cells.
Gazyva is used in combination with another cancer medicine called chlorambucil to treat chronic lymphocytic leukemia.
Gazyva is also used in combination with other cancer medicines to treat follicular lymphoma (a type of non-Hodgkin lymphoma), or to help delay the progression of this disease.
